Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07113210) titled 'Quality of Life in Presbyopic Patients Who Are Treated With Qlosi' on Aug. 2.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Southern College of Optometry
Condition:
Presbyopia
Glasses
Dry Eye
Intervention:
Drug: pilocarpine HCL ophthalmic solution
Recruitment Status: Recruiting
Phase: Phase 4
Date of First Enrollment: July 18, 2025
Target Sample Size: 36
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07113210
Published by...